首页>
外国专利>
COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH A MTOR INHIBITOR.
COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH A MTOR INHIBITOR.
展开▼
机译:无糖化的CD20抗体与MTOR抑制剂的联合治疗。
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention is directed to the combination therapy of an afucosylated anti-CD20 antibody with a m TOR inhibitor for the treatment of cancer, especially to the combination therapy of CD20 expressing cancers with an afucosylated humanized B-Ly1 antibody and a mTOR inhibitor such as Temsirolimus or Everolimus.
展开▼